NewAmsterdam Pharma Company N.V. Stock Deutsche Boerse AG
Equities
KH6
NL00150012L7
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
After market 16:00:01 | |||
16.4 EUR | +1.23% | 17.35 | +5.79% |
Sales 2024 * | 8.61M 9.38M 12.79M | Sales 2025 * | 6.3M 6.86M 9.35M | Capitalization | 1.55B 1.69B 2.3B |
---|---|---|---|---|---|
Net income 2024 * | -209M -228M -310M | Net income 2025 * | -139M -152M -206M | EV / Sales 2024 * | 180 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 246 x |
P/E ratio 2024 * |
-7.46
x | P/E ratio 2025 * |
-11.6
x | Employees | 40 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.29% |
Latest transcript on NewAmsterdam Pharma Company N.V.
1 day | +7.10% | ||
1 week | -1.80% | ||
Current month | +1.23% | ||
1 month | -15.90% | ||
3 months | -21.15% | ||
6 months | +92.94% | ||
Current year | +67.35% |
Date | Price | Change |
---|---|---|
24-06-03 | 16.4 | +1.23% |
24-05-31 | 16.2 | -2.41% |
24-05-30 | 16.6 | -2.35% |
24-05-29 | 17 | +3.66% |
24-05-28 | 16.4 | -0.61% |
Delayed Quote Deutsche Boerse AG, June 03, 2024 at 09:29 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.55% | 118B | |
+12.66% | 106B | |
-2.53% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.92% | 15.56B | |
+6.19% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- NAMS Stock
- KH6 Stock